0
     

Report Added
Report already added
Attention Deficit Hyperactivity Disorder Market - Global Outlook and Forecast 2022-2028

Attention Deficit Hyperactivity Disorder Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Attention Deficit Hyperactivity Disorder in Global, including the following market information:

Global Attention Deficit Hyperactivity Disorder Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Attention Deficit Hyperactivity Disorder market was valued at 19 million in 2021 and is projected to reach US$ 27 million by 2028, at a CAGR of 4.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stimulants Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Attention Deficit Hyperactivity Disorder include Eli Lilly, Novartis, Takeda, Pfizer, GlaxoSmithKline, Mallinckrodt, Hisamitsu, Johnson & Johnson and Purdue Parma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Attention Deficit Hyperactivity Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Attention Deficit Hyperactivity Disorder Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Attention Deficit Hyperactivity Disorder Market Segment Percentages, by Type, 2021 (%)
Stimulants Drugs
Non-stimulants Drugs
Global Attention Deficit Hyperactivity Disorder Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Attention Deficit Hyperactivity Disorder Market Segment Percentages, by Application, 2021 (%)
Pediatric
Adolescent
Adults
Global Attention Deficit Hyperactivity Disorder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Attention Deficit Hyperactivity Disorder Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Attention Deficit Hyperactivity Disorder revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Attention Deficit Hyperactivity Disorder revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Novartis
Takeda
Pfizer
GlaxoSmithKline
Mallinckrodt
Hisamitsu
Johnson & Johnson
Purdue Parma
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Attention Deficit Hyperactivity Disorder Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Attention Deficit Hyperactivity Disorder Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Attention Deficit Hyperactivity Disorder Overall Market Size
2.1 Global Attention Deficit Hyperactivity Disorder Market Size: 2021 VS 2028
2.2 Global Attention Deficit Hyperactivity Disorder Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Attention Deficit Hyperactivity Disorder Players in Global Market
3.2 Top Global Attention Deficit Hyperactivity Disorder Companies Ranked by Revenue
3.3 Global Attention Deficit Hyperactivity Disorder Revenue by Companies
3.4 Top 3 and Top 5 Attention Deficit Hyperactivity Disorder Companies in Global Market, by Revenue in 2021
3.5 Global Companies Attention Deficit Hyperactivity Disorder Product Type
3.6 Tier 1, Tier 2 and Tier 3 Attention Deficit Hyperactivity Disorder Players in Global Market
3.6.1 List of Global Tier 1 Attention Deficit Hyperactivity Disorder Companies
3.6.2 List of Global Tier 2 and Tier 3 Attention Deficit Hyperactivity Disorder Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Attention Deficit Hyperactivity Disorder Market Size Markets, 2021 & 2028
4.1.2 Stimulants Drugs
4.1.3 Non-stimulants Drugs
4.2 By Type - Global Attention Deficit Hyperactivity Disorder Revenue & Forecasts
4.2.1 By Type - Global Attention Deficit Hyperactivity Disorder Revenue, 2017-2022
4.2.2 By Type - Global Attention Deficit Hyperactivity Disorder Revenue, 2023-2028
4.2.3 By Type - Global Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Attention Deficit Hyperactivity Disorder Market Size, 2021 & 2028
5.1.2 Pediatric
5.1.3 Adolescent
5.1.4 Adults
5.2 By Application - Global Attention Deficit Hyperactivity Disorder Revenue & Forecasts
5.2.1 By Application - Global Attention Deficit Hyperactivity Disorder Revenue, 2017-2022
5.2.2 By Application - Global Attention Deficit Hyperactivity Disorder Revenue, 2023-2028
5.2.3 By Application - Global Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Attention Deficit Hyperactivity Disorder Market Size, 2021 & 2028
6.2 By Region - Global Attention Deficit Hyperactivity Disorder Revenue & Forecasts
6.2.1 By Region - Global Attention Deficit Hyperactivity Disorder Revenue, 2017-2022
6.2.2 By Region - Global Attention Deficit Hyperactivity Disorder Revenue, 2023-2028
6.2.3 By Region - Global Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Attention Deficit Hyperactivity Disorder Revenue, 2017-2028
6.3.2 US Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.3.3 Canada Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.3.4 Mexico Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Attention Deficit Hyperactivity Disorder Revenue, 2017-2028
6.4.2 Germany Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.4.3 France Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.4.4 U.K. Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.4.5 Italy Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.4.6 Russia Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.4.7 Nordic Countries Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.4.8 Benelux Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Attention Deficit Hyperactivity Disorder Revenue, 2017-2028
6.5.2 China Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.5.3 Japan Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.5.4 South Korea Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.5.5 Southeast Asia Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.5.6 India Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Attention Deficit Hyperactivity Disorder Revenue, 2017-2028
6.6.2 Brazil Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.6.3 Argentina Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Attention Deficit Hyperactivity Disorder Revenue, 2017-2028
6.7.2 Turkey Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.7.3 Israel Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.7.4 Saudi Arabia Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
6.7.5 UAE Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
7 Players Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder Major Product Offerings
7.1.4 Eli Lilly Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.1.5 Eli Lilly Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Attention Deficit Hyperactivity Disorder Major Product Offerings
7.2.4 Novartis Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Takeda
7.3.1 Takeda Corporate Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Attention Deficit Hyperactivity Disorder Major Product Offerings
7.3.4 Takeda Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.3.5 Takeda Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Attention Deficit Hyperactivity Disorder Major Product Offerings
7.4.4 Pfizer Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.4.5 Pfizer Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Major Product Offerings
7.5.4 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.5.5 GlaxoSmithKline Key News
7.6 Mallinckrodt
7.6.1 Mallinckrodt Corporate Summary
7.6.2 Mallinckrodt Business Overview
7.6.3 Mallinckrodt Attention Deficit Hyperactivity Disorder Major Product Offerings
7.6.4 Mallinckrodt Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.6.5 Mallinckrodt Key News
7.7 Hisamitsu
7.7.1 Hisamitsu Corporate Summary
7.7.2 Hisamitsu Business Overview
7.7.3 Hisamitsu Attention Deficit Hyperactivity Disorder Major Product Offerings
7.7.4 Hisamitsu Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.7.5 Hisamitsu Key News
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Corporate Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder Major Product Offerings
7.8.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.8.5 Johnson & Johnson Key News
7.9 Purdue Parma
7.9.1 Purdue Parma Corporate Summary
7.9.2 Purdue Parma Business Overview
7.9.3 Purdue Parma Attention Deficit Hyperactivity Disorder Major Product Offerings
7.9.4 Purdue Parma Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
7.9.5 Purdue Parma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Attention Deficit Hyperactivity Disorder Market Opportunities & Trends in Global Market
Table 2. Attention Deficit Hyperactivity Disorder Market Drivers in Global Market
Table 3. Attention Deficit Hyperactivity Disorder Market Restraints in Global Market
Table 4. Key Players of Attention Deficit Hyperactivity Disorder in Global Market
Table 5. Top Attention Deficit Hyperactivity Disorder Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Attention Deficit Hyperactivity Disorder Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Attention Deficit Hyperactivity Disorder Revenue Share by Companies, 2017-2022
Table 8. Global Companies Attention Deficit Hyperactivity Disorder Product Type
Table 9. List of Global Tier 1 Attention Deficit Hyperactivity Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Attention Deficit Hyperactivity Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Attention Deficit Hyperactivity Disorder Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Attention Deficit Hyperactivity Disorder Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Attention Deficit Hyperactivity Disorder Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Attention Deficit Hyperactivity Disorder Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Attention Deficit Hyperactivity Disorder Product Offerings
Table 32. Eli Lilly Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Attention Deficit Hyperactivity Disorder Product Offerings
Table 35. Novartis Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 36. Takeda Corporate Summary
Table 37. Takeda Attention Deficit Hyperactivity Disorder Product Offerings
Table 38. Takeda Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Attention Deficit Hyperactivity Disorder Product Offerings
Table 41. Pfizer Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Attention Deficit Hyperactivity Disorder Product Offerings
Table 44. GlaxoSmithKline Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 45. Mallinckrodt Corporate Summary
Table 46. Mallinckrodt Attention Deficit Hyperactivity Disorder Product Offerings
Table 47. Mallinckrodt Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 48. Hisamitsu Corporate Summary
Table 49. Hisamitsu Attention Deficit Hyperactivity Disorder Product Offerings
Table 50. Hisamitsu Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 51. Johnson & Johnson Corporate Summary
Table 52. Johnson & Johnson Attention Deficit Hyperactivity Disorder Product Offerings
Table 53. Johnson & Johnson Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
Table 54. Purdue Parma Corporate Summary
Table 55. Purdue Parma Attention Deficit Hyperactivity Disorder Product Offerings
Table 56. Purdue Parma Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Attention Deficit Hyperactivity Disorder Segment by Type in 2021
Figure 2. Attention Deficit Hyperactivity Disorder Segment by Application in 2021
Figure 3. Global Attention Deficit Hyperactivity Disorder Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Attention Deficit Hyperactivity Disorder Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Attention Deficit Hyperactivity Disorder Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder Revenue in 2021
Figure 8. By Type - Global Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 9. By Application - Global Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 10. By Region - Global Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 11. By Country - North America Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 12. US Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 16. Germany Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 17. France Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 24. China Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 28. India Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 30. Brazil Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
Figure 33. Turkey Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Takeda Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mallinckrodt Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Hisamitsu Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson & Johnson Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Purdue Parma Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Attention Deficit Hyperactivity Disorder Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW